Skip to main content
main-content

Diabetes complications and comorbidities: Hypoglycemia

Interactive patient case study

Renal complications in diabetic ketoacidosis

Renal complications in diabetic ketoacidosis

This 15-minute case presents likely causes of renal complications in diabetic ketoacidosis and explains how to identify the signs and symptoms of renal complications to ensure early initiation of appropriate treatment.

Get more on: Diabetic ketoacidosis | Pediatric diabetes | Nephropathy

Interactive patient case study

Hypoglycemia and technology

Hypoglycemia and technology

This 15-minute case presents the identification of problematic hypoglycemia and the appropriate use and monitoring of different technologies in the context of reducing the occurrence and risk of hypoglycemia.

Get more on: Hypoglycemia | Devices and technology | Pediatric diabetes

medwireNews editor's pick

EASE: Add-on empagliflozin improves glycemic control in type 1 diabetes

Pills

The addition of empagliflozin to insulin therapy reduces glycated hemoglobin levels in patients with type 1 diabetes, indicate findings from the phase III EASE-2 and 3 trials.

Journal article

Prevention and management of severe hypoglycemia and hypoglycemia unawareness: Incorporating sensor technology

Woman with flash glucose monitor (symbolic image with model)

In this paper, the authors report on the current scientific evidence on the effectiveness of continuous glucose monitoring sensor technology in the prevention of severe hypoglycemia and hypoglycemia unawareness [read more].
Lucidi P et al. Curr Diab Rep 2018; 18: 83. doi: 10.1007/s11892-018-1065-6

Get more on:  Devices and technology | Diabetic complications | Type 1 diabetes

Case study

Acute illness while on a SGLT2 inhibitor and ketogenic diet

AdobeStock_88855376

Advisory Board member Theresa Smyth tackles an emergency case involving a type 2 diabetes patient on a new diet and treated with empagliflozin. What went wrong and how should he be managed? [Read more].

Get more on: SGLT2 inhibitors | Diet and nutritional management | Case studies

Expert opinion editorial

The ambulatory glucose profile: What, why, and how?

Ambulatory glucose profile

Editorial Board member Lori Berard discusses how the ambulatory glucose profile is revolutionizing the analysis of blood glucose and glycemic control for patients and practitioners [read more].

Get more on: Continuous glucose monitoring | Flash glucose monitoring | Glycemic control 

medwireNews editor's pick

Continuing metformin advisable for patients starting sulfonylurea treatment

Metformin formula

Research shows that starting second-line sulfonylurea treatment is associated with an increased risk for cardiovascular and hypoglycemic events among patients with type 2 diabetes in clinical practice, although the risk is less if they continue using metformin rather than switching completely.

Journal article

Long-term effect of the color record method in self-monitoring of blood glucose on metabolic parameters in type 2 diabetes: A 2-year follow-up of the Color IMPACT study

Paper ECG

This article evaluates the potential long-term effect of two different color indication methods for self-monitoring of blood glucose on metabolic parameters in insulin-treated type 2 diabetes [read more].
Nishimura A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0457-6

Get more on:  Devices and technology | Type 2 diabetes

medwireNews editor's pick

NPH insulin may be as good as analogs in type 2 diabetes

Insulin pens

Patients with type 2 diabetes in clinical practice have similar outcomes regardless of whether they use long-acting insulin analogs or the cheaper human neutral protamine Hagedorn insulin, say researchers.

medwireNews editor's pick

Fluid management strategy absolved of neurologic injury blame in childhood DKA

Child on iv drip

Neither the rate of administration nor the sodium chloride content of replacement fluids given to children with diabetic ketoacidosis influences their neurologic outcomes, show the results of the PECARN DKA FLUID Study.

medwireNews

01-17-2019 | Glucokinase activators | News

Hepatic glucokinase activation may improve glycemic control in type 2 diabetes

The hepatoselective glucokinase activator TTP399 reduces glycated hemoglobin levels without increasing the risk for hypoglycemia among patients with type 2 diabetes, suggest findings from the phase IIb AGATA trial.

10-04-2018 | Empagliflozin | EASD 2018 | News

EASE: Add-on empagliflozin improves glycemic control in type 1 diabetes

The addition of empagliflozin to insulin therapy reduces glycated hemoglobin levels in patients with type 1 diabetes, indicate findings from the phase III EASE-2 and 3 trials.

08-22-2018 | Insulin pumps | News

Predictive insulin-suspend algorithm cuts hypoglycemia without consequent hyperglycemia

The Tandem Basal-IQ predictive low-glucose suspend insulin delivery system significantly reduces the proportion of time adults and children spend in hypoglycemia during 24-hour usage, show findings from the randomized crossover PROLOG trial.

Interactive patient case study

12-21-2018 | Hypoglycemia | Case study

Hypoglycemia and technology

Develop and test your knowledge on the use of different technologies to reduce hypoglycemia risk through this practical example and self-assessment authored by Riccardo Bonfanti and Francesco Chiarelli. This 15 minutes case presents the identification of problematic hypoglycemia and the appropriate use and monitoring of different technologies in the context of reducing the occurrence and risk of hypoglycemia.

Themed collections

06-25-2018 | SGLT2 inhibitors | Themed collection | Collection

Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

An updated collection of articles focusing on the mechanism of action and clinical use of sodium-glucose cotransporter-2 inhibitors in patients with diabetes.

Journal articles and book chapters

08-29-2018 | Continuous glucose monitoring | Review | Article

Designing the glucose telemetry for hospital management: From bedside to the nursing station

Satyarengga M, Siddiqui T, Spanakis EK. Curr Diab Rep 2018; 18: 87. doi: 10.1007/s11892-018-1067-4

08-15-2018 | Pregnancy | Review | Article

Inpatient glycemic management of the pregnant patient

Yeh T, Yeung M, Mendelsohn Curanaj FA. Curr Diab Rep 2018; 18: 73. doi: 10.1007/s11892-018-1045-x

08-15-2018 | Nephropathy | Review | Article

Inpatient glycemic management in the setting of renal insufficiency/failure/dialysis

Iyengar R, Franzese J, Gianchandani R. Curr Diab Rep 2018; 18: 75. doi: 10.1007/s11892-018-1044-y

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

image credits